|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 15739658.1 (espacenet) (Federated) (European Patent Register), 20150709 | Patent/reg. no. and date | DK/EP 3166628, 20200101 | Publication date | 20170517 | Priority no. and date | GB 201412290, 20140710 | EP pub. no. and date |
EP 3166628 20170517 | Effective date | | Applicant/owner | Cambridge Enterprise Limited, The Old Schools Trinity Lane
Cambridge, Cambridgeshire CB2 1TN, GB | Applicant ref. no. | P023633EPDK1 | Inventor | MORRELL, Nicholas W, c/o University of Cambridge School of Clinical Medicine Department of Medicine Box 157 Addenbrooke's Hospital Hills Road
Cambridge Cambridgeshire CB2 0QQ, GB, LI, Wei, c/o University of Cambridge School of Clinical Medicine Department of Medicine Box 157 Addenbrooke's Hospital Hills Road
Cambridge Cambridgeshire CB2 0QQ, GB, UPTON, Paul D, c/o University of Cambridge School of Clinical Medicine Department of Medicine Box 157 Addenbrooke's Hospital Hills Road
Cambridge Cambridgeshire CB2 0QQ, GB | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 38/18 (2006.01) , A61P 11/00 (2006.01) , A61P 9/10 (2006.01) | Title | TERAPEUTISK ANVENDELSE AF KNOGLEMORFOGENETISKE PROTEINER | Int. application no. | GB2015051989 | Int. publication no. | WO2016005756 | Related patent (certificate) | | Status | Ændret EP patent ikke valid i DK | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |